Loading...
At this year's meeting of the American Society of Clinical Oncology (ASCO 2019), held May 31 to June 4 in Chicago, investigators discussed the latest findings in cancer research. The editors of NEJM Journal Watch Oncology and Hematology were on hand to report highlights of the conference. Associate Editor David H. Ilson, MD, PhD, reviewed key presentations on new gastrointestinal cancer treatments. All meeting abstracts can be viewed in the (ASCO meeting library).
Tempero and colleagues reported results of the phase III APACT trial (abstract 4000) comparing adjuvant gemcitabine with or without nab-paclitaxel in 866 patients with resected pancreatic adenocarcinoma …